4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-061600
Director sold 1,184 shares at $14.20 ($16,813)
- Director acquired 2,366 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gallagher Carol Giltner · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-15 | Exercise or conversion : show line 1 in the form | +1,549 | 110,105 | D | ||
| 2017-11-15 | Exercise or conversion : show line 2 in the form | +817 | 110,922 | D | ||
| 2017-11-16 | Sale : show line 3 in the form | −1,184 | $14.20 | $16,813 | 109,738 | D |
| Open-market sales · 1,184 sh · avg $14.20 · $16,813 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-15 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −1,549 | 1,548 | D |
| 2017-11-15 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −817 | 1,362 | D |
Loading xslF345X03/doc4.xml…